Villoria-González, A.; Zierfuss, B.; Parzer, P.; Heuböck, E.; Zujovic, V.; Waidhofer-Söllner, P.; Ponleitner, M.; Rommer, P.; Göpfert, J.; Forss-Petter, S.;
et al. Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. Biomolecules 2023, 13, 1696.
https://doi.org/10.3390/biom13121696
AMA Style
Villoria-González A, Zierfuss B, Parzer P, Heuböck E, Zujovic V, Waidhofer-Söllner P, Ponleitner M, Rommer P, Göpfert J, Forss-Petter S,
et al. Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. Biomolecules. 2023; 13(12):1696.
https://doi.org/10.3390/biom13121696
Chicago/Turabian Style
Villoria-González, Andrea, Bettina Zierfuss, Patricia Parzer, Elisabeth Heuböck, Violetta Zujovic, Petra Waidhofer-Söllner, Markus Ponleitner, Paulus Rommer, Jens Göpfert, Sonja Forss-Petter,
and et al. 2023. "Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders" Biomolecules 13, no. 12: 1696.
https://doi.org/10.3390/biom13121696
APA Style
Villoria-González, A., Zierfuss, B., Parzer, P., Heuböck, E., Zujovic, V., Waidhofer-Söllner, P., Ponleitner, M., Rommer, P., Göpfert, J., Forss-Petter, S., Berger, J., & Weinhofer, I.
(2023). Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. Biomolecules, 13(12), 1696.
https://doi.org/10.3390/biom13121696
